Tonix Pharmaceuticals Announces Plan to Develop TNX-601 CR Tablets for Once-Daily Treatment of Major Depressive Disorder, in Addition to PTSD, After Successful Completion of Phase 1 Pharmacokinetic...

TNX-601 CR Active Ingredient, Tianeptine, is Approved and Marketed as an Immediate Release Three-Times-a-Day Antidepressant in Europe, Asia, Russia and Latin America First Efficacy Trial Planned ex-U.S. in 2020. NEW YORK, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp.

Posted: 2019-12-16 21:58:00

Read Full Article

< Prev		Next >

Donate now!

Donate now, contribute to EGR & NEXUS-IBA projects

Free consultation

If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.

We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.

EGR local time

Verse of the day

Think not that I am come to destroy the law, or the prophets: I am not come to destroy, but to fulfil. Matthew, 5. 17

Main Menu

Polls

Is wealth an indication of God’s favor or blessing?

	Yes
	No
	Somehow
	I do not know

EGR European Gospel Radio